Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 41 Issue 5, May 2020

Precision medicine based on molecular signatures of patients has shown increasing value in cancer treatment. This review summarized the common strategies of CRISPR-cas9 screening and the application of this screening in precision medicine including identification of new targets and biomarkers and elucidation of mechanisms leading to drug resistance.

Review Article

Top of page ⤴

Article

Top of page ⤴

Correction

Top of page ⤴

Search

Quick links